“There doesn’t appear to be an obvious way of knowing who these catastrophic life-threatening side effects are likely to affect,” said Professor Robert Howard (UCL Psychiatry) on the safety of the promising Alzheimer’s drug lecanemab.
Read: Mail Online (2), More: ITV, Mirror
Close
